Organ transplantation is a crucial medical procedure, as it is often the only treatment for patients suffering from end-stage organ failure. Unfortunately, the shortage of donor organs limits the number of patients whose lives can be saved. 
| INTRODUC TI ON
Tibetan macaques, who belong to the superfamily ofCercopithecoidea, are also known as Chinese stump-tailed macaques or MilneEdwards' macaques. 1 They are one of the largest monkeys in China and are mainly found in the provinces of Sichuan, southern Shanxi, southern Gansu, Anhui, Hunan, Hubei, Guangxi, Guangdong, Jiangxi, Guizhou, Yunnan, and Fujian. 2 According to the research of Jack Fooden, the taxonomic status of Tibetan macaques is separated from that of Macaca arctoides because of differences in genitalia. 3 Based on external morphology, fur color, skeletal characteristics, and geographical distribution, Tibetan macaques are divided into four subspecies: M thibetan thibetana, M thibetan esau, M thibetan guiahouensis, and M thibetan huangshanensis, whose distribution is detailed in Figure 1 . 4 The main subspecies, M thibetana thibetana, received its name by Milne-Edwards in 1870. 5 As a national second-class protected animal, Tibetan macaques live in natural reserves characterized by broad-leaved evergreen and subtropical deciduous areas. They feed fruits, plants, and invertebrates. 6, 7 The use of Tibetan macaques for scientific purposes has been approved by the State Forestry Administration of the People's
Republic of China, due to various advantages, namely large size, long life (over 20 years), gentle temperament, and suitability for cooperative handling. 8 As the Sichuan province is the main habitat of Organ transplantation is the most effective treatment in various end-stage organ failure settings: not only does it save lives, but it also significantly improves patients' quality of life. 9 Thanks to the development of new surgical techniques and the widespread use of immunosuppressants, the survival rate of grafts has considerably improved in the past decades. 10 However, the shortage of donor organs and transplant intolerance are urgent problems facing the field of organ transplantation. The scarcity of donor organs severely restricts the development and application of organ transplantation and hinders the only effective treatment for end-stage organ failure.
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In 1964, Reemtsma et al transplanted chimpanzee kidneys to patients suffering from renal failure. All patients received immunotherapy. However, one of the patients died of electrolyte disturbance after 9 months of renal function. 12 In the same year, Hardy et al performed the first chimpanzee-to-human heart transplant.
The patient died 90 minutes later. 13 Similarly, Starzl et al reported six cases surviving for 98 days after receiving baboon liver transplants, among which four died because of sepsis and two died because of immune rejection. 14 Despite the successful xenotransplantation of chimpanzee kidneys to patients with renal failure, the nonhuman primate donors are no longer considered potential sources for xenotransplants, as they represent an endangered species that hosts deadly viruses.
In recent decades, the development of biomedical technologies including gene-editing techniques such as CRISPR-Cas9
and TALEN has led to promising applications in research on biosafety and immune barriers between species. 15 Because of their short breeding cycle, low feeding cost, and suitability for genetic modifications, pigs are ideal donors for xenotransplantation in humans. 16 Additionally, the large pig population and low risk of cross-species infection make them convenient donors. 17 As of today, pig-to-nonhuman primate xenotransplantation is the most leading experimental model in preclinical trials. In China, many In adult Tibetan macaques, the value of blood urea nitrogen (BUN) ranges between 2.20 and 12.09 mmol/L, and the value of creatinine ranges between 32.1 and 122.5 μmol/L: These ranges are similar to those in humans. 8 These similarities are shown in Table 1 , whereas disease-related changes, thus paving the way for the use of Tibetan macaques in xenotransplantation. Another finding related to immunity was the identification of the major histocompatibility complex (MHC) class II DQB (MhcMath-DQB1), which has allele polymorphism. 26 MHC is closely related to the immune response and immune regulation of the body.
| THE G ENOMI C SUPERI ORITIE S OF TIB E TA N M AC AQ U E S
Additionally, it controls the immune rejection in transplantation. 27 The most common alleles are MhcMath-DQB1 28 These results suggest that, despite slight differences in structure, the TLR5 proteins perform a similar immune function as both species are exposed to analogous pathogenic microorganisms. 28 The complete mitochondrial genome of M thibetana contains 16 540 bp, consisting of 13 protein-coding genes, two rRNA genes (12S rRNA, 16S rRNA), 22 tRNA genes, and a control region. 29 Their genes are distributed similarly as in other mammalians and primates' mitochondrial genome, and the majority of genes are encoded on the H chain. 29 Generally speaking, these genomic analyses provide useful information for a better understanding of the application potential of Tibetan macaques in xenotransplantation. Macaques represent the ideal animal model to conduct basic research on human health and disease, due to their similarity to humans in terms of tissue structure, physiology, metabolic functions, biology, and behavior (see Table 3 antithrombotics can properly inhibit dysfunctional coagulation in pig-to-nonhuman primate xenotransplantation. 38 In conclusion, considering the many recent scientific breakthroughs regarding genetically modified pigs, immunosuppressive agents, and a variety of anti-inflammatory drugs, it seems safe to assume that the main issues facing xenotransplantation will gradually be solved. China, especially Sichuan's Mount Emei, is home to many kinds of monkeys, among which large numbers of Tibetan macaques. Thanks to the implementation of gene-editing in the process of genetic modification of potential pig donors, through techniques such as CRISPR-Cas9, TALEN, and SCNT, great progress has been made in preclinical xenotransplantation of pig-to-Tibetan macaques. 
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